Page last updated: 2024-10-20
uracil and Exanthem
uracil has been researched along with Exanthem in 2 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hayakawa, N | 1 |
| Matsumoto, K | 1 |
| Sato, A | 1 |
| Sakamoto, H | 1 |
| Ezaki, T | 1 |
| Maeda, T | 1 |
| Ninomiya, A | 1 |
| Nakamura, S | 1 |
Reviews
1 review available for uracil and Exanthem
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Trials
1 trial available for uracil and Exanthem
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Other Studies
1 other study available for uracil and Exanthem
| Article | Year |
|---|---|
Efficacy of tegafur-uracil (UFT) administration in castration-resistant prostate cancer patients with a history of both alternative antiandrogen therapy and estramustine phosphate sodium hydrate therapy.
Topics: Age Factors; Aged; Aged, 80 and over; Androgen Antagonists; Antimetabolites, Antineoplastic; Antineo | 2014 |